Effect of choriocarcinoma supernatant on natural killer and lymphokine-activated killer cell activity

V. Fülöp, I. Szigetvari, J. Szepesi, I. Gati

Research output: Article

1 Citation (Scopus)

Abstract

The effect of JEG-3 choriocarcinoma supernatant on human natural killer cell and lymphokine-activated killer cell activity was investigated. Choriocarcinoma supernatants from JEG-3 cell lines were obtained at the time of their optimal growth. K562 erythroblastoid cells were used as target cells for natural killer and lymphokine-activated killer cell mediated lysis in a 51Cr release assay. The choriocarcinoma supernatants had a significant dose-dependent suppressive effect on natural killer and lymphokine-activated killer cell activity. This suppression was more expressed at high effector:target cell ratios. Therefore, choriocarcinoma supernatants appear to have potent inhibitory effects on many aspects of cellular immunity, although, additional studies should be performed to futher characterize and identify immunoregulatory molecule(s) in choriocarcinoma supernatants.

Original languageEnglish
Pages (from-to)239-247
Number of pages9
JournalActa Medica Hungarica
Volume49
Issue number3-4
Publication statusPublished - 1992

Fingerprint

Lymphokine-Activated Killer Cells
Choriocarcinoma
Natural Killer Cells
K562 Cells
Cellular Immunity
Cell Line
Growth

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effect of choriocarcinoma supernatant on natural killer and lymphokine-activated killer cell activity. / Fülöp, V.; Szigetvari, I.; Szepesi, J.; Gati, I.

In: Acta Medica Hungarica, Vol. 49, No. 3-4, 1992, p. 239-247.

Research output: Article

Fülöp, V. ; Szigetvari, I. ; Szepesi, J. ; Gati, I. / Effect of choriocarcinoma supernatant on natural killer and lymphokine-activated killer cell activity. In: Acta Medica Hungarica. 1992 ; Vol. 49, No. 3-4. pp. 239-247.
@article{84b1b500212d4c389ab4a575198772c0,
title = "Effect of choriocarcinoma supernatant on natural killer and lymphokine-activated killer cell activity",
abstract = "The effect of JEG-3 choriocarcinoma supernatant on human natural killer cell and lymphokine-activated killer cell activity was investigated. Choriocarcinoma supernatants from JEG-3 cell lines were obtained at the time of their optimal growth. K562 erythroblastoid cells were used as target cells for natural killer and lymphokine-activated killer cell mediated lysis in a 51Cr release assay. The choriocarcinoma supernatants had a significant dose-dependent suppressive effect on natural killer and lymphokine-activated killer cell activity. This suppression was more expressed at high effector:target cell ratios. Therefore, choriocarcinoma supernatants appear to have potent inhibitory effects on many aspects of cellular immunity, although, additional studies should be performed to futher characterize and identify immunoregulatory molecule(s) in choriocarcinoma supernatants.",
keywords = "choriocarcinoma supernatant, immunosuppression, lymphokine-activated killer cell, natural killer cell",
author = "V. F{\"u}l{\"o}p and I. Szigetvari and J. Szepesi and I. Gati",
year = "1992",
language = "English",
volume = "49",
pages = "239--247",
journal = "Acta Medica Hungarica",
issn = "0236-5286",
publisher = "Akademiai Kiado",
number = "3-4",

}

TY - JOUR

T1 - Effect of choriocarcinoma supernatant on natural killer and lymphokine-activated killer cell activity

AU - Fülöp, V.

AU - Szigetvari, I.

AU - Szepesi, J.

AU - Gati, I.

PY - 1992

Y1 - 1992

N2 - The effect of JEG-3 choriocarcinoma supernatant on human natural killer cell and lymphokine-activated killer cell activity was investigated. Choriocarcinoma supernatants from JEG-3 cell lines were obtained at the time of their optimal growth. K562 erythroblastoid cells were used as target cells for natural killer and lymphokine-activated killer cell mediated lysis in a 51Cr release assay. The choriocarcinoma supernatants had a significant dose-dependent suppressive effect on natural killer and lymphokine-activated killer cell activity. This suppression was more expressed at high effector:target cell ratios. Therefore, choriocarcinoma supernatants appear to have potent inhibitory effects on many aspects of cellular immunity, although, additional studies should be performed to futher characterize and identify immunoregulatory molecule(s) in choriocarcinoma supernatants.

AB - The effect of JEG-3 choriocarcinoma supernatant on human natural killer cell and lymphokine-activated killer cell activity was investigated. Choriocarcinoma supernatants from JEG-3 cell lines were obtained at the time of their optimal growth. K562 erythroblastoid cells were used as target cells for natural killer and lymphokine-activated killer cell mediated lysis in a 51Cr release assay. The choriocarcinoma supernatants had a significant dose-dependent suppressive effect on natural killer and lymphokine-activated killer cell activity. This suppression was more expressed at high effector:target cell ratios. Therefore, choriocarcinoma supernatants appear to have potent inhibitory effects on many aspects of cellular immunity, although, additional studies should be performed to futher characterize and identify immunoregulatory molecule(s) in choriocarcinoma supernatants.

KW - choriocarcinoma supernatant

KW - immunosuppression

KW - lymphokine-activated killer cell

KW - natural killer cell

UR - http://www.scopus.com/inward/record.url?scp=0027012847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027012847&partnerID=8YFLogxK

M3 - Article

C2 - 1345462

AN - SCOPUS:0027012847

VL - 49

SP - 239

EP - 247

JO - Acta Medica Hungarica

JF - Acta Medica Hungarica

SN - 0236-5286

IS - 3-4

ER -